Talviraline
Talviraline is a non-nucleoside reverse transcriptase (NNRT) inhibitor that is primarily used to inhibit the replication of human immunodeficiency virus type 1 (HIV-1) . Talviraline inhibits the viral replication process by binding to a specific site of HIV-1 reverse transcriptase (RT) . Talviraline can be used to study the potential countermeasures and safety of HIV-1 infection[1].
Product Specifications
CAS Number
163451-80-7
Product Name Alternative
HBY 097
UNSPSC
12352005
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/talviraline.html
Purity
99.43
Solubility
10 mM in DMSO
Smiles
CC(C)OC(N1C2=CC(OC)=CC=C2NC([C@@H]1CSC)=S)=O
Molecular Formula
C15H20N2O3S2
Molecular Weight
340.46
References & Citations
[1]Kleim J P, et al. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication[J]. Antimicrobial agents and chemotherapy, 1995, 39 (10) : 2253-2257.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1119043 Inquire
Recombinant Pseudomonas putida DNA mismatch repair protein mutL (mutL), partial
Sign In for Pricing
View Details 
MBS2128773-01 0.1 mL
Biotin Linked Monoclonal Antibody to Platelet Factor 4 (PF4)
Sign In for Pricing
View Details MBS2128773-02 0.2 mL
Biotin Linked Monoclonal Antibody to Platelet Factor 4 (PF4)
Sign In for Pricing
View Details